Status
Conditions
Treatments
About
Falls are a major concern for individuals with Multiple Sclerosis (MS), negatively affecting balance, mobility, independence, and quality of life, while increasing the risk of injury. This randomized controlled trial aims to investigate the effects of a 5-week exercise-based balance program on fall-related outcomes in individuals with MS. Thirty participants with MS will be randomly allocated to either an intervention group or a control group. The intervention group will follow an Otago-based exercise program supplemented with additional balance and mobility tasks, while the control group will follow the Otago Exercise Program alone. Participants in both groups will perform home-based exercises three times per week. Outcomes will be assessed before and after the intervention period using the FICSIT-4 for balance, the Timed Up and Go test for mobility, the Falls Efficacy Scale-International (FES-I) for fear of falling, and the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for walking limitations.
Full description
Falls are a common and clinically significant problem in individuals with Multiple Sclerosis (MS), primarily associated with impairments in balance, mobility, muscle strength, and neuromuscular coordination. Exercise-based interventions focusing on balance and functional mobility constitute a core component of fall-prevention strategies; however, the optimal structure and intensity of such programs for individuals with MS remain under investigation.
This randomized controlled trial aims to investigate the effects of a 5-week exercise-based balance program on fall-related outcomes in individuals with MS. A total of 30 adults with a confirmed diagnosis of MS will be randomly allocated to either an intervention group or a control group using a parallel-group design.
Both groups will participate in a 5-week exercise program that includes home-based exercise performed three times per week. The control group will follow the Otago Exercise Program alone, a standardized and widely used balance and lower-limb strengthening program for fall prevention. The intervention group, in addition to performing the home-based Otago Exercise Program, will participate in one supervised exercise session per week. During these supervised sessions, the Otago-based program will be supplemented with additional balance and mobility tasks of progressively increasing difficulty, designed to challenge static and dynamic postural control, enhance neuromuscular coordination, and promote functional movement adaptability.
Outcome assessments will be conducted at baseline and immediately after completion of the intervention period. Balance will be assessed using the Four-Stage Balance Test (FICSIT-4), functional mobility will be evaluated with the Timed Up and Go test, fear of falling will be measured using the Falls Efficacy Scale-International (FES-I), and perceived walking limitations will be assessed using the 12-item Multiple Sclerosis Walking Scale (MSWS-12).
It is expected that participants in both groups will demonstrate improvements in balance and functional mobility following the intervention period, reflecting the effects of structured balance and strengthening exercises. It is further hypothesized that participants in the intervention group will exhibit greater improvements in balance performance and functional mobility compared with those in the control group, due to the addition of supervised balance and mobility tasks with increased task complexity. Reductions in fear of falling and perceived walking limitations are also anticipated, although these changes may be less pronounced than improvements observed in performance-based outcome measures.
The findings of this study are expected to contribute to a better understanding of exercise-based fall-prevention strategies for individuals with MS and to inform the design of targeted rehabilitation programs aimed at improving balance and mobility in this population.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
30 participants in 2 patient groups
Loading...
Central trial contact
Paris Iakovidis, PhD; Dimitrios Lytras, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal